-
-
-
-
-
-
-
Vivos Therapeutics (VVOS) Misses Q1 EPS by 7c
-
-
-
-
-
-
-
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
-
-
-
-
-
-
-
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Vivos Therapeutics, Inc. (VVOS) Tops Q3 EPS by 88c
-
-
-
-
-
-
-
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
-
-
-
-
-
-
-
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call
-
1,222,391 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

